Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer

NCT00404066 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: Lapatinib
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Docetaxel
DRUG: Pegfilgrastim
DRUG: Filgrastim
DRUG: Dexamethasone
DRUG: Trastuzumab

Sponsor

George Albert Fisher

Collaborators

[object Object]
[object Object]